These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1450904)

  • 1. Neural sensitivity to pentylenetetrazol convulsions in inbred and selectively bred mice.
    Kosobud AE; Cross SJ; Crabbe JC
    Brain Res; 1992 Oct; 592(1-2):122-8. PubMed ID: 1450904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs.
    Kosobud AE; Crabbe JC
    Brain Res; 1990 Aug; 526(1):8-16. PubMed ID: 2078820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of GABAA receptor subunit mRNAs in ethanol-naive withdrawal seizure resistant (WSR) vs. withdrawal seizure prone (WSP) mouse brain.
    Keir WJ; Morrow AL
    Brain Res Mol Brain Res; 1994 Sep; 25(3-4):200-8. PubMed ID: 7808218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
    Crabbe JC; Young ER; Tam B; Kosobud A; Belknap JK; Laursen SE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):154-9. PubMed ID: 3093669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.
    Beckley EH; Fretwell AM; Tanchuck MA; Gililland KR; Crabbe JC; Finn DA
    Neuropharmacology; 2008 Feb; 54(2):365-74. PubMed ID: 18045626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and -resistant mice.
    Finn DA; Crabbe JC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):782-90. PubMed ID: 9918589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1985 Sep; 234(3):624-8. PubMed ID: 3875710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraining administration of pentylenetetrazol dissociates gabapentin effects on memory consolidation from that on memory retrieval process in mice.
    Blake MG; Boccia MM; Acosta GB; Baratti CM
    Neurosci Lett; 2004 Sep; 368(2):211-5. PubMed ID: 15351451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I corticosteroid receptors modulate PTZ-induced convulsions of withdrawal seizure prone mice.
    Roberts AJ; Crabbe JC; Keith LD
    Brain Res; 1993 Oct; 626(1-2):143-8. PubMed ID: 8281425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal.
    Metten P; Belknap JK; Crabbe JC
    Behav Brain Res; 1998 Sep; 95(1):113-22. PubMed ID: 9754883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice.
    Akula KK; Dhir A; Bishnoi M; Kulkarni SK
    Neurosci Lett; 2007 Sep; 425(1):39-42. PubMed ID: 17720312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice.
    Finn DA; Roberts AJ; Crabbe JC
    Alcohol Clin Exp Res; 1995 Apr; 19(2):410-5. PubMed ID: 7625575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of kindling or brain stimulation on pentylenetetrazol-induced convulsion susceptibility.
    Cain DP
    Epilepsia; 1980 Jun; 21(3):243-9. PubMed ID: 7379768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions.
    Jelenkovic AV; Jovanovic MD; Stanimirovic DD; Bokonjic DD; Ocic GG; Boskovic BS
    Exp Biol Med (Maywood); 2008 Nov; 233(11):1389-94. PubMed ID: 18703755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase.
    Itoh K; Watanabe M
    Neuroscience; 2009 Mar; 159(2):735-43. PubMed ID: 19162139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pentylenetetrazol-induced seizures and brain pentylenetetrazol levels in mice.
    Yonekawa WD; Kupferberg HJ; Woodbury DM
    J Pharmacol Exp Ther; 1980 Sep; 214(3):589-93. PubMed ID: 7400961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic differences in behavioral sensitivity to a neuroactive steroid.
    Finn DA; Roberts AJ; Lotrich F; Gallaher EJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):820-8. PubMed ID: 9023296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system uptake kinetics of pentylenetetrazol in the developing rat.
    Haberer LJ; Pollack GM
    Biopharm Drug Dispos; 1991; 12(1):59-71. PubMed ID: 2039812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptors mediate the enhancing effects of corticosterone on convulsion susceptibility in mice.
    Roberts AJ; Keith LD
    J Pharmacol Exp Ther; 1994 Aug; 270(2):505-11. PubMed ID: 8071844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of serotonergic mechanisms in the anticonvulsant effect of stress in mice treated with pentylenetetrazol.
    De-Lima TC; Rae GA
    Braz J Med Biol Res; 1988; 21(2):333-5. PubMed ID: 2974312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.